News | March 17, 2023
Jubilant receives additional CAD 23.8 million loan facility for CMO Montreal facility
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
This loan is in addition to earlier announced CAD 25 million loan committed by the Province of Quebec
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
Proposed combination enhances Pfizer’s position as a leading company in oncology
Kyndryl's multi-cloud management solution leverages AI-based, cloud-hosted models to provide real-time metrics, events, logs, and traces
Dr. Hubbard brings more than 35 years of experience in the biopharmaceutical and pharma-tech services industries and CROs.
Olanzapine Orally Disintegrating Tablets are used to treat certain mental/mood conditions
Erythromycin Tablets USP, 250 mg and 500 mg are used to prevent and treat infections in many different parts of the body
Ashland’s pharmaceutical business is well known for acetylenics, cellulosics, and film coatings
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Subscribe To Our Newsletter & Stay Updated
